WIERENGA WENDALL 4
4 · CYTOKINETICS INC · Filed Dec 16, 2024
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
WIERENGA WENDALL
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2024-12-16−742→ 0 totalExercise: $7.37From: 2015-02-02Exp: 2025-01-02→ Common Stock (742 underlying) - Sale
Common Stock
2024-12-16$48.61/sh−742$36,069→ 24,559 total - Exercise/Conversion
Common Stock
2024-12-16$7.37/sh+742$5,469→ 25,301 total
Footnotes (1)
- [F1]This option shall vest and become exercisable as to 5,936 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2016.